Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Interleukin 10 production by human melanoma.

Sato T, McCue P, Masuoka K, Salwen S, Lattime EC, Mastrangelo MJ, Berd D.

Clin Cancer Res. 1996 Aug;2(8):1383-90.

2.

Differential expression of transforming growth factor beta 1 and interleukin 10 in progressing and regressing areas of primary melanoma.

Conrad CT, Ernst NR, Dummer W, Bröcker EB, Becker JC.

J Exp Clin Cancer Res. 1999 Jun;18(2):225-32.

PMID:
10464712
3.

Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines.

Ijland SA, Jager MJ, Heijdra BM, Westphal JR, Peek R.

Melanoma Res. 1999 Oct;9(5):445-50.

PMID:
10596910
4.

Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.

Schietroma C, Cianfarani F, Lacal PM, Odorisio T, Orecchia A, Kanitakis J, D'Atri S, Failla CM, Zambruno G.

Cancer. 2003 Aug 15;98(4):789-97.

5.

Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10.

Ekmekcioglu S, Okcu MF, Colome-Grimmer MI, Owen-Schaub L, Buzaid AC, Grimm EA.

Melanoma Res. 1999 Jun;9(3):261-72.

PMID:
10465582
6.

IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops.

Barzegar C, Meazza R, Pereno R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boyé D, Doucet C, Taoufik Y, Ritz J, Musselli C, Mishal Z, Jasmin C, Indiveri F, Ferrini S, Azzarone B.

Oncogene. 1998 May 14;16(19):2503-12.

7.

Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.

García-Vázquez MD, Boyano MD, Cañavate ML, Gardeazabal J, de Galdeano AG, López-Michelena T, Ratón JA, Izu R, Díaz-Ramón JL, Díaz-Pérez JL.

Eur Cytokine Netw. 2000 Dec;11(4):654-61.

8.

Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.

Weinreich DM, Elaraj DM, Puhlmann M, Hewitt SM, Carroll NM, Feldman ED, Turner EM, Spiess PJ, Alexander HR.

Cancer Res. 2003 Sep 15;63(18):5957-61.

9.

Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.

Flørenes VA, Lu C, Bhattacharya N, Rak J, Sheehan C, Slingerland JM, Kerbel RS.

Oncogene. 1999 Jan 28;18(4):1023-32.

10.

Expression and production of interleukin 10 in human myeloma cell lines.

Otsuki T, Yamada O, Yata K, Sakaguchi H, Kurebayashi J, Yawata Y, Ueki A.

Br J Haematol. 2000 Dec;111(3):835-42.

PMID:
11122145
11.

Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions.

Dummer W, Bastian BC, Ernst N, Schänzle C, Schwaaf A, Bröcker EB.

Int J Cancer. 1996 May 29;66(5):607-10.

12.

Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.

Langley RR, Carlisle R, Ma L, Specian RD, Gerritsen ME, Granger DN.

Microcirculation. 2001 Oct;8(5):335-45.

PMID:
11687945
13.
14.

Flow cytometric measurement of intracellular Th1 and Th2 cytokine production by human villous and extravillous cytotrophoblast.

Sacks GP, Clover LM, Bainbridge DR, Redman CW, Sargent IL.

Placenta. 2001 Jul;22(6):550-9.

PMID:
11440543
15.

Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.

Mühlbauer M, Langenbach N, Stolz W, Hein R, Landthaler M, Buettner R, Bosserhoff AK.

Clin Cancer Res. 1999 May;5(5):1099-105.

16.

Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.

Lee JH, Torisu-Itakara H, Cochran AJ, Kadison A, Huynh Y, Morton DL, Essner R.

Clin Cancer Res. 2005 Jan 1;11(1):107-12.

17.

Inhibition of the elicitation phase of contact hypersensitivity by thymidine dinucleotides is in part mediated by increased expression of interleukin-10 in human keratinocytes.

Curiel-Lewandrowski C, Venna SS, Eller MS, Cruikshank W, Dougherty I, Cruz PD Jr, Gilchrest BA.

Exp Dermatol. 2003 Apr;12(2):145-52.

PMID:
12702142
18.
19.

In vivo human melanoma cytokine production: inverse correlation of GM-CSF production with tumor depth.

Hensley C, Spitzler S, McAlpine BE, Lynn M, Ansel JC, Solomon AR, Armstrong CA.

Exp Dermatol. 1998 Dec;7(6):335-41.

PMID:
9858136
20.

Interferon gamma induction in human melanoma cell/allogeneic leukocyte co-cultures is enhanced by interleukin 18 but drug resistant melanoma cells are poorer inducers of IFN-gamma.

Micallef MJ, Darmanin S, Buhagiar JA, Camilleri-Podesta MT, Yamauchi H, Kurimoto M, Inglott AS, Ellul-Micallef R.

Int Immunopharmacol. 2001 Feb;1(2):295-305.

PMID:
11360930

Supplemental Content

Support Center